COFCO Biotechnology Co., Ltd.

Sümbol: 000930.SZ

SHZ

6.57

CNY

Turuhind täna

-21.1266
P/E suhe
-2.7465
PEG suhe
12.13B
MRK Cap
0.09%
DIV tootlus

COFCO Biotechnology Co., Ltd. (000930-SZ) Finantsaruanded

Q: Mis on COFCO Biotechnology Co., Ltd. (000930.SZ) koguvara?

COFCO Biotechnology Co., Ltd. (000930.SZ) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete COFCO Biotechnology Co., Ltd. (000930.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes COFCO Biotechnology Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	1481.1	1016.6	1116	662.3	700.5	772.9	554.8	617.8	537.1	284.5	255.9	353.4	406.6	508.6	694	552.7	734.7	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9	29.2	1.3
balance-sheet.row.short-term-investments	2.1	3.8	-24.4	-21.1	-26.5	-26.4	0	5.5	0	-5.8	0.6	0.3	1.2	3.8	10	0	35.6	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	1549.6	2608.5	2147	4052.6	1726.9	2861.6	688.4	469.1	509.4	826.6	694.3	566.1	626.9	558.3	380.1	539.1	1019	968.9	731.6	510.3	580.8	225.8	189.4	57.2	36.2	26.7	35.4	42
balance-sheet.row.inventory	2534.3	3763.2	4052.3	4991.5	2770	3867.3	619.1	563.4	737.8	1265.4	923	1188.3	773.6	982.5	625.3	843.3	709.6	594.6	951.6	619.2	332.6	170.8	69.2	78	40.6	36.7	28.2	23.8
balance-sheet.row.other-current-assets	470.3	282.6	319.1	195	1530.5	1904.7	36.3	21.2	31.8	-189.4	-208.7	-100.9	-92.3	-70.4	-29.5	-53.9	-174.6	141.4	-48.6	-22.3	35.9	111.1	119.4	228.6	302.1	119.4	47.6	22.7
balance-sheet.row.total-current-assets	6035.3	7671	7634.4	9901.4	6727.9	9406.5	1898.6	1671.5	1816	2187.1	1664.5	2007	1714.7	1979	1669.8	1881.2	2288.8	2029.6	2255.2	1670.1	1536.2	869.4	684.5	525.9	624.2	244.8	140.3	89.9
balance-sheet.row.property-plant-equipment-net	8678	8612	8650	8493.8	8394.1	8774.9	3397.5	3130.4	3315.9	4225.7	4420.6	4371	4283.5	4455.1	4607.6	5034.4	5065.8	5229.5	4696.8	4034.1	3001.4	2095.1	1680.8	779	431.6	245.8	167.3	100.8
balance-sheet.row.goodwill	366	366	366	366	366	366	366	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	602.7	610.6	629.7	852.7	823.9	898.9	445.6	333	342.6	340.9	356.6	368.1	354.3	375.7	359	176.7	161.4	139	57.3	16.9	8.8	5.9	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	968.7	976.6	995.8	1218.8	1189.9	1265	445.6	333	342.6	340.9	356.6	368.1	354.3	375.7	359	176.7	161.4	139	57.3	16.9	8.8	5.9	0	0	0	0	0	0
balance-sheet.row.long-term-investments	535.4	536.9	536.6	538.5	592.2	610.6	39.1	33.6	0	44.9	38.5	38.8	37.9	35.3	56.4	0	39.4	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	265	164.5	202.8	133.3	131.7	131.9	118.9	9.3	0	46.2	40.4	35.1	45.2	73	63.6	38.1	55.7	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	75.5	139.2	42.6	198.8	121	98.7	56.3	257.2	173.7	19.4	30.8	39.2	41.8	4.7	10.3	73.7	35.6	290.4	383.3	179	170.6	69.7	82.5	47	24.5	0	0	0
balance-sheet.row.total-non-current-assets	10522.5	10429.3	10427.7	10583.1	10429	10881	4057.3	3763.5	3832.2	4677.1	4886.9	4852.2	4762.6	4943.9	5096.9	5322.9	5357.8	5658.8	5137.3	4229.9	3180.8	2170.7	1763.3	826	456.1	245.8	167.3	100.8
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	16557.9	18100.3	18062.1	20484.5	17156.9	20287.6	5955.9	5435	5648.2	6864.2	6551.4	6859.1	6477.4	6922.9	6766.7	7204.1	7646.6	7688.5	7392.5	5900	4717.1	3040.1	2447.8	1351.9	1080.3	490.6	307.6	190.6
balance-sheet.row.account-payables	681.9	919.6	920.2	845.8	854.8	984.9	315.1	309	197.3	582.2	332.6	287.8	278.3	476	564	1268	1652.7	1326.8	1511.4	1316.5	912.6	511.8	376.8	276.9	132.9	100.8	63	36.7
balance-sheet.row.short-term-debt	3398.9	2929.1	2871.7	6640.2	2731.4	5158.9	2261.2	2126.9	2461.3	2118	1908.5	2203.6	2343.1	2965.7	2986	3035.9	2781.9	2432.8	2343.8	1802.3	1413.2	783.9	389.2	198.7	139.8	58.8	52	39.7
balance-sheet.row.tax-payables	47.6	91.4	64.5	119.9	78.5	119.9	46.1	42.1	24.3	6.3	18.4	-22.6	-1.9	-13	64.1	-9.9	-50.5	-6.5	5.7	-26.3	-38.3	-11.8	-8.2	34.1	36.2	27.5	12.7	8.3
balance-sheet.row.long-term-debt-total	165.6	296.9	523.7	189.7	274.7	645	535.3	377.8	564.1	688.3	779.1	853.1	373	413.6	562.3	603	983	1110	591.3	884.9	630.2	190.5	115.2	170.2	178.2	112.3	65.8	19.9
Deferred Revenue Non Current	56.5	59	50.9	64.5	67.5	62.6	18	18.9	20.6	44.2	48.2	0	0	0	0	0	-912.9	0	0	0	0	0	0	0	-178.2	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	794.7	1034.1	32.4	55.9	1633.6	3541.2	33.1	37	19.9	45.2	58.2	54.3	58.8	63.5	37.3	44.8	66.4	544.3	95.2	55.9	28.4	15.1	3.7	3.3	1.8	0.8	0.9	2.1
balance-sheet.row.total-non-current-liabilities	492.5	427.3	712.9	359.3	412.7	836.9	741.2	944.7	1108	754.6	831	942.7	617.2	438.9	592.2	616.9	1054.4	1177.6	591.4	889.5	637.2	191.2	116.3	173.6	183.9	112.3	65.8	19.9
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	196.6	105.6	117.3	121.7	17.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	5634.3	5588.8	6303.4	9682.7	6954	10641.7	3994.5	3729.2	4074.5	3760.4	3457.9	3790	3538.7	4321.2	4425	5169.6	5734.5	5667.4	4957.5	4111.9	3105.2	1534.1	1067.2	759.8	508.4	340.3	208.6	122.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1864.7	1865.3	1865.7	1865.8	1847.6	1847.6	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964.4	964	391.9	318.6	318.6	177	147	147	87	44.8	43
balance-sheet.row.retained-earnings	1411.7	3152.3	2601.3	1645.1	1060.4	514.4	-278.2	-500.4	-627.5	809.8	802.4	788.9	676.3	390.2	185.5	-50.2	-108.5	-50	339.6	273.4	273.4	192.4	127.2	56.2	49	15.6	46.1	21.2
balance-sheet.row.accumulated-other-comprehensive-income-loss	1226.6	1131.5	989.9	888.8	996.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	5948.5	5950.8	5940.4	5994	5923	6864.1	1117.6	1096.9	1098.7	1114.6	1105.4	1086.3	1074.9	1027.8	973.4	931.5	960.1	1002.6	993.8	1080	997.9	979.2	1065.8	388.9	376	47.7	8.1	3.7
balance-sheet.row.total-stockholders-equity	10451.6	12099.9	11397.4	10393.7	9827.4	9226.1	1803.8	1560.9	1435.6	2888.9	2872.2	2839.7	2715.7	2382.4	2123.3	1845.8	1816	1917	2297.5	1745.3	1589.9	1490.1	1370.1	592.1	571.9	150.3	99	67.9
balance-sheet.row.total-liabilities-and-stockholders-equity	16557.9	18100.3	18062.1	20484.5	17156.9	20287.6	5955.9	5435	5648.2	6864.2	6551.4	6859.1	6477.4	6922.9	6766.7	7204.1	7646.6	7688.5	7392.5	5900	4717.1	3040.1	2447.8	1351.9	1080.3	490.6	307.6	190.6
balance-sheet.row.minority-interest	402	411.6	361.3	408.1	375.5	419.8	157.6	144.9	138.2	214.9	221.3	229.4	223.1	219.3	218.4	188.7	96.1	104.1	137.6	42.8	21.9	15.9	10.5	0	0	0	0	0
balance-sheet.row.total-equity	10853.6	12511.5	11758.7	10801.8	10202.9	9645.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	535.4	536.9	512.1	517.3	565.7	584.2	39.1	39.1	39.1	39.1	39.1	39.1	39.1	39.1	66.4	73.7	74.9	290.4	383.3	179	170.6	69.7	82.3	47	24.5	0	0	0
balance-sheet.row.total-debt	3761.1	3226	3395.4	6829.9	3006.1	5804	2796.5	2504.7	3025.3	2806.3	2687.6	3056.8	2716.1	3379.3	3548.3	3638.9	3764.9	3542.8	2935.1	2687.2	2043.4	974.4	504.4	368.9	318	171.1	117.8	59.5
balance-sheet.row.net-debt	2280	2209.4	2279.5	6167.6	2305.6	5031	2241.7	1892.4	2488.3	2521.8	2432.3	2703.7	2310.8	2874.5	2864.3	3086.3	3065.7	3218.1	2314.6	2124.4	1456.4	612.7	197.9	206.8	72.7	109.2	88.6	58.2

Rahavoogude aruanne

COFCO Biotechnology Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	1060.9	1133	628.2	558.9	517.4	249.7	133.2	-1495	31.6	50.5	201.5	361.3	301.2	279.9	61.7	17.3	-384.8	139.1	107.1	104.7	114.1	110	86	40.6	15.6
cash-flows.row.depreciation-and-amortization	458.2	446.3	436.4	425.3	609.5	181.1	168.1	275.7	271.5	256.5	241.9	260.1	250.2	267.3	222.6	266.4	299.2	207.2	126.6	73	61.2	41.7	31.1	15.2	4.6
cash-flows.row.deferred-income-tax	36.1	-62.2	-3.3	-0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-5	62.2	3.3	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-1261.9	2701.8	-4471.1	1670.7	-2886.4	88	340.8	190.7	-233.6	254.1	-384.4	-185.6	-477.1	-324.4	-233	675.7	-270.7	-95.3	23	-79.6	-10.4	-80.2	-16	-251.5	-22
cash-flows.row.account-receivables	-1051.9	2418.2	-2276.3	960.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	83.1	760.3	-2462.3	983.4	-1741.4	-117.8	257	418.1	-289.3	264.8	-413.8	179.8	-357.2	218.1	-133.8	-115	357	-332.4	-286.5	-161.9	-101.3	-22.7	-37.3	-3.9	0
cash-flows.row.account-payables	-329.1	-414.5	270.7	-273	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	36.1	-62.2	-3.3	-0.5	-1145	205.8	83.7	-227.3	55.6	-10.7	29.5	-365.3	-119.9	-542.5	-99.2	790.7	-627.7	237.1	309.5	82.3	90.9	-57.5	21.4	-247.6	0
cash-flows.row.other-non-cash-items	420.1	560.4	495.7	994.9	836.3	228.9	142.5	914.3	137.3	176.6	209.7	258	239	366.7	387.4	126	428	134.2	81.5	46.2	25.2	20.2	25.7	51.5	21.3
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-565.8	-1109.8	-987.5	-900.8	-868.4	-639.2	-160.5	-83.9	-129.5	-240.6	-160.7	-149.9	-178.4	-162.4	-243.9	-337.2	-444.8	-726.1	-703.4	-790.9	-503.3	-678.1	-160.4	-171.6	-7.2
cash-flows.row.acquisitions-net	305.7	160.5	107.8	151.7	0	7449.1	0	0	0	0	-19.7	0	0	0.5	0	337.2	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-32.6	270.4	-21.1	-32	0	-6740.9	0	0	0	0	170.9	0	0	-30.7	0	-45	-2.3	-354.3	-35.6	-238	-3.8	-58.5	-22.5	-17.5	0
cash-flows.row.sales-maturities-of-investments	14.8	1.6	6.3	106.7	47.2	2.2	5.8	5.8	5.7	3.7	3.7	3.7	32.2	6.7	5.7	191.9	2.3	8	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-22.7	9.4	-4.5	44	-33.5	-639.2	13.8	0.6	1.2	7.9	-160.7	8.8	1.3	33.5	32.3	-337.2	107	10.2	-92.2	111.9	0.9	0.2	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-300.6	-667.9	-899	-630.4	-854.7	-568	-140.9	-77.5	-122.6	-229.1	-166.5	-137.5	-145	-152.5	-205.8	-190.3	-337.8	-1062.3	-831.2	-917	-506.2	-736.5	-182.9	-189	-7.2
cash-flows.row.debt-repayment	-6493.2	-11592.7	-5566.1	-8894.5	-7613.7	-2708.1	-3325.4	-3293.6	-3140.6	-2970.4	-3654.9	-3599.2	-4020.9	-3431	-3059.1	-3342.8	-2557.6	-1954.6	-2032.2	-1003.6	-797.2	-268.2	-170.9	-192.9	-38.7
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-554.7	-277.3	-164.4	-196	-191.5	-114.7	-131.3	-180.7	-166.1	-181.8	-212.7	-200.4	-197.6	-242.6	-302	-233.8	-206.1	-137.7	-118.6	-73.7	-41.3	-25.9	-90.6	-14.1	-7.8
cash-flows.row.other-financing-activites	6453.7	8168.4	9485.1	6000.6	9127.9	2588	2895.5	3895.4	3253.9	2550.8	3715.9	3150.3	3878.2	3367.9	2989.2	3064.9	2741.1	2829.9	2619.7	2068.7	1208.9	1083.1	234.4	723.7	79.1
cash-flows.row.net-cash-used-provided-by-financing-activities	-594.3	-3701.7	3754.6	-3089.9	1322.7	-234.8	-561.2	421	-52.9	-601.3	-151.7	-649.3	-340.3	-305.7	-371.8	-511.7	-22.6	737.6	468.9	991.3	370.3	789	-27.1	516.7	32.6
cash-flows.row.effect-of-forex-changes-on-cash	40.4	-4.3	-0.5	1.4	5.7	0.5	2.3	-4.8	-2.1	-5.1	-2.8	-6.6	-7.2	0.1	-7.6	-8.8	-7.2	-2.8	-0.1	6.5	0.9	0.2	0	0	0
cash-flows.row.net-change-in-cash	-146.1	467.7	-55.8	-69.2	-449.6	-54.7	85	224.6	29.2	-97.8	-52.2	-99.5	-179.1	131.3	-146.5	374.5	-295.8	57.6	-24.1	225.3	55.2	144.4	-83.1	183.4	44.9
cash-flows.row.cash-at-end-of-period	963	1109.1	641.4	697.2	766.4	539.4	594.1	509.1	284.5	255.3	353.1	405.4	504.8	684	552.7	699.2	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9
cash-flows.row.cash-at-beginning-of-period	1109.1	641.4	697.2	766.4	1216	594.1	509.1	284.5	255.3	353.1	405.4	504.8	684	552.7	699.2	324.7	620.5	562.8	587	361.7	306.5	162.1	245.3	61.9	16.9
cash-flows.row.operating-cash-flow	708.4	4841.6	-2910.9	3649.7	-923.3	747.7	784.7	-114.2	206.8	737.7	268.7	693.9	313.3	589.4	438.7	1085.3	71.7	385.2	338.3	144.4	190.1	91.7	126.8	-144.2	19.5
cash-flows.row.capital-expenditure	-565.8	-1109.8	-987.5	-900.8	-868.4	-639.2	-160.5	-83.9	-129.5	-240.6	-160.7	-149.9	-178.4	-162.4	-243.9	-337.2	-444.8	-726.1	-703.4	-790.9	-503.3	-678.1	-160.4	-171.6	-7.2
cash-flows.row.free-cash-flow	142.7	3731.8	-3898.4	2748.9	-1791.7	108.4	624.2	-198.1	77.2	497.1	108	544	134.9	427	194.8	748.1	-373	-341	-365.1	-646.5	-313.1	-586.4	-33.6	-315.8	12.3

Kasumiaruande rida

COFCO Biotechnology Co., Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 000930.SZ brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	20289.8	19918.1	23468.6	19909.4	19472	17703.9	6275.9	5603.4	6457.3	7153.2	7339.9	7730.4	7401.3	5967.2	5011	4801.9	4178.1	4398.2	3261.3	2198.2	1547.4	1199.4	853.2	705.2	482.9	345.6	229	102.2
income-statement-row.row.cost-of-revenue	19341.4	17666.6	20842.8	17827.7	16735.5	14803.5	5596.5	4830.8	6482.2	6463.1	6652.7	6955.5	6695.1	5758.5	4752.4	4864.9	4471	4424.6	2922	1807.2	1260.9	954.2	660.1	503.9	381.8	268.8	169.5	69.5
income-statement-row.row.gross-profit	948.4	2251.5	2625.7	2081.7	2736.5	2900.5	679.4	772.5	-25	690.1	687.2	774.9	706.2	208.7	258.6	-63.1	-292.9	-26.4	339.4	391.1	286.5	245.2	193.1	201.3	101.1	76.8	59.5	32.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-534.2	75	259	400.1	-258.2	3.9	104.2	215.9	76.8	119.7	202	368	652.8	891.3	871.5	871.3	819.4	324.4	214.3	13.3	2	36	19.1	3.3	0.8	1.1	0	0.1
income-statement-row.row.operating-expenses	1403.8	553.1	752.6	860	1130	1516.3	297	607.3	588	604.1	636.2	668.1	597.7	517.7	437.6	429.5	361.5	438.9	208.9	158	96.9	89.7	75.9	77.3	42.3	25.8	18.2	9.6
income-statement-row.row.cost-and-expenses	20745.3	18219.7	21595.5	18687.7	17865.5	16319.7	5893.6	5438.1	7070.2	7067.2	7288.9	7623.6	7292.8	6276.2	5190	5294.4	4832.5	4863.5	3130.8	1965.2	1357.7	1043.9	735.9	581.2	424.1	294.6	187.7	79.1
income-statement-row.row.interest-income	16.2	16.2	15.4	10.6	9.9	5	2.1	4.1	4.6	3.2	5.1	4.2	7.3	5.4	5.5	8	36.2	37.6	12.8	5.3	5.9	2.5	7.1	2.3	0	0	0	0
income-statement-row.row.interest-expense	112.8	87.1	157.8	94.3	162.1	163.1	106.4	156	177.6	148.2	154.7	193.4	190.6	162.7	230.9	286.6	282.5	228.3	116.8	98.4	63.5	28.9	23	23.5	11.7	9.2	6.8	4.1
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-84.2	9.7	-543.5	-393.5	-990.1	-766.4	-123.3	-29.4	-861.1	-26.3	3.2	158.3	389.8	640.4	502.9	561.1	693.8	125.7	80.4	-83.8	-48.2	5.1	1.2	-24.2	-11.2	-8.1	-6.9	-4.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-534.2	75	259	400.1	-258.2	3.9	104.2	215.9	76.8	119.7	202	368	652.8	891.3	871.5	871.3	819.4	324.4	214.3	13.3	2	36	19.1	3.3	0.8	1.1	0	0.1
income-statement-row.row.total-operating-expenses	-84.2	9.7	-543.5	-393.5	-990.1	-766.4	-123.3	-29.4	-861.1	-26.3	3.2	158.3	389.8	640.4	502.9	561.1	693.8	125.7	80.4	-83.8	-48.2	5.1	1.2	-24.2	-11.2	-8.1	-6.9	-4.1
income-statement-row.row.interest-expense	112.8	87.1	157.8	94.3	162.1	163.1	106.4	156	177.6	148.2	154.7	193.4	190.6	162.7	230.9	286.6	282.5	228.3	116.8	98.4	63.5	28.9	23	23.5	11.7	9.2	6.8	4.1
income-statement-row.row.depreciation-and-amortization	509.2	888.7	446.3	436.4	425.3	609.5	181.1	168.1	275.7	271.5	256.5	241.9	260.1	250.2	267.3	222.6	266.4	299.2	207.2	126.6	73	61.2	41.7	31.1	15.2	4.6	6.7	4.1
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-455.4	1350.2	1926.6	1195.5	1656.4	614.2	154.9	-57.8	-1547.6	-57.1	-144	-96.8	-144.2	-557.7	-539.8	-802.8	-780	-687.9	26.9	159.2	146.6	133.5	102.7	99.3	47.3	41.8	34.6	19
income-statement-row.row.income-before-tax	-539.7	1359.9	1383.1	801.9	666.3	617.8	259.1	135.9	-1474.1	59.7	54.1	265	498.2	331.3	324	68.6	39.4	-351.5	226	160.9	145	165.1	120.1	101.2	47.8	42.9	34.5	19
income-statement-row.row.income-tax-expense	73.8	298.9	250.1	173.8	107.5	100.4	9.4	2.6	20.9	28.1	3.7	63.6	136.9	59.9	44.1	34.7	22.2	30.9	70.2	53.8	40.3	51	10.1	15.2	7.2	6.4	5.2	2.9
income-statement-row.row.net-income	-601.6	1058.5	1129.6	593.1	592.8	483	237.3	127.1	-1418	35.2	50.7	183	355.1	263.9	251.9	26.4	25.8	-384.8	139.1	101.1	98.8	110.2	110	86	40.6	36.5	29.3	16.2